Bioanalytical Systems, Inc., or BASi, (BASI) said CFO Jacqueline Lemke has been named to the additional posts of interim President & CEO. Lemke succeeds Anthony Chilton, who has resigned as CEO to pursue other opportunities.
"...As interim President and CEO, with continuing responsibility as CFO, we expect Jackie to complete the transformation of BASi and deliver the growth and profitability we believe this company is capable of delivering. Board member Richard Johnson and I, with more than 60 years of combined major pharma and CRO experience, will work closely with Jackie during this interim period," said John Landis, Chairman.
Lemke has more than 20 years of experience in critical financial reporting and management positions, most recently as Vice President of Finance and Global CFO of Remy, Inc.
BASi also announced the resignation of Alberto Hidalgo, Vice President, Business Development and Marketing.
For comments and feedback: editorial@rttnews.com